00:00AstraZeneca announces $50 billion investment in U.S. amid tariff pressure
00:10Investment seems to be flowing into the United States.
00:15Just this Wednesday morning, U.S. President Donald Trump announced that Japan would invest $550 billion in the U.S.
00:23No sooner had that news settled than it was revealed that British pharmaceutical company AstraZeneca would invest $50 billion in the United States.
00:32Of course, AstraZeneca made this announcement last Monday.
00:36Dear viewers, if you like this news, please like it and share your comments in the comment box.
00:43According to a Reuters report, U.K.-based pharmaceutical company AstraZeneca announced on Monday that it would invest $50 billion by 2030
00:51to increase its research and drug manufacturing capabilities in the United States.
00:57This is the latest large investment in the pharmaceutical industry in the context of Trump's tariff policy taking effect.
01:03The company stated in a press release that this investment would be used to build a new drug manufacturing plant in Virginia, USA.
01:12In addition, research and cell therapy component production capacity will be expanded in Maryland, Massachusetts, California, Indiana, and Texas.
01:21Furthermore, the company's U.S.-based clinical trial supply network will be modernized, and ongoing investments for new drug innovation will also be funded.
01:31AstraZeneca stated that through this expansion plan, the company aims to reach an annual revenue target of $80 billion by 2030, with half of it coming from the United States.
01:42In 2024, more than 40% of the company's annual revenue came from the United States.
01:48As the world's largest pharmaceutical market, the U.S. market is valued at $635 billion.
01:55The company was prioritizing the U.S. market even before Trump's return to power.
02:00After the Trump administration's threat of imposing tariffs on the pharmaceutical industry and its push for increased domestic production,
02:08many pharmaceutical companies are one-by-one expanding their operations in the United States.
02:13Although historically, the pharmaceutical industry has been exempt from trade wars.
02:18Trump has repeatedly urged pharmaceutical companies to produce the drugs and components they sell in the U.S. domestically.
02:25At the same time, he wants the price of medicines for Americans to decrease and be equal to prices in other countries.
02:33In an announcement in Washington, AstraZeneca CEO Pascal Soriatt said,
02:37Other countries in the world must also share the cost of research and innovation.
02:42The U.S. cannot bear this research cost alone.
02:45The office of U.S. Commerce Secretary Howard Lutnick is currently conducting an investigation into pharmaceutical imports,
02:53which could pave the way for new tariffs in the future.
02:56Lutnick said,
02:57For a long time, Americans have been dependent on foreign supplies for medicines.
03:02The Trump administration's new tariff policy is working to remove this structural weakness.
03:07Although Trump has repeatedly threatened to impose tariffs on the pharmaceutical industry,
03:12Earlier this month, he hinted that industries would be given one year to 18 months to complete their preparations.
03:19AstraZeneca stated that while this announcement in the U.S. is primarily centered on the country's current policy environment,
03:26some of their expenses for building future healthcare systems were predetermined.
03:30The company also stated that in addition to this $50 billion commitment,
03:34they are also implementing an additional investment plan of $3.5 billion announced in November 2024.
03:42Prior to AstraZeneca's $50 billion commitment,
03:46in April, Swiss pharmaceutical company Roche also announced the same amount of investment in the United States.
03:52In addition, this year, several pharmaceutical companies,
03:56including Eli Lilly, Johnson & Johnson, Novartis, and Sanofi,
04:00have announced new investment plans in the United States.
04:03quinhoed committee proposals including the business in the United States zulke teplus komme,
04:14tobaccoiver, Texas, Florian Crs,resident, Europe, and America,
04:15which Mitarbeiter has come out of Russia thatoks,
04:18they have acted along,
04:18which is four months,
04:19as well as thร nh usions to ะฒััััะฟ with Trump ฮ PLA,
